Fighting COVID-19 with testing for your communities

Expertise in virologic diagnostics for infectious diseases

ABLDx was formed to leverage the collective expertise of its management team, a group that previously worked together in virology and infectious disease management. The team was responsible for bringing the first commercially available product for HIV RNA viral load testing to market. Now, they are combining their deep understanding of molecular testing with cutting edge technology to assure you that every product developed is fueled by infectious disease expertise that includes research, development, clinical utility, commercialization and user experience.

Chalom Sayada, MD, Ph.D.
Chalom Sayada, MD, Ph.D.
Founder and Chairman
Meet Our Team

UltraGene® Combo2Screen SARS-CoV-2 Assay
ABLDx has submitted an EUA application to the FDA for this first COVID-19 test.

A biotechnology company specialized in virology diagnostics

A biotechnology company specialized in virology diagnostics

AdvancedDx Biological Laboratories (ABLDx) is a virologic diagnostic solutions company focused on commercializing solutions that will advance public health in the Americas. ABLDx will be initially focused on fighting the COVID-19 global pandemic by bringing tests to local communities in the U.S. With a philosophy that “to measure is to know,” ABLDx recognizes that testing lies at the critical intersection of patient care, the collection of sufficient data to inform vaccine development, and the need to create public health and safety measures.

We're committed to long-term solutions in disease management

ABL has three platform solutions for COVID-19 diagnostic testing:

  • Molecular: UltraGene® Combo2Screen SARS-CoV-2 Assay

    Early detection of COVID-19 through a qPCR molecular assay (coming soon).

  • Genotype: DeepChek® 8-plex SARS-CoV-2 Genotyping Assay

    (now available for Research Use Only. Not for use in diagnostic procedures.). Click here for a PDF with more details.

  • Serology: SARS-CoV-2 Antibody Test

    (More information coming soon.)

We're committed to long-term solutions in disease management

Stay up to date on our response to COVID-19.

We'll send you updates on resources such as customer communications, fact sheets and testing information.